NYQ · Drug Manufacturers - Specialty & Generic

Bausch Health Companies Inc. (BHC) Stock

$6.04 -1.79% NYQ: BHC Healthcare

Valuation

MetricValue
Price$6.04
Market Cap$2.26B
P/E Ratio-2.08
P/B Ratio-1.30
P/S Ratio0.21
EPS (TTM)$0.00
52-Week High$8.00
52-Week Low$4.33
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE88.77%
ROA-4.43%
ROCE13.63%
Gross Margin21.29%
Operating Margin21.28%
Net Margin-10.12%
Debt/Equity-11.73
Current Ratio1.47

Annual Financials (USD)

Metric20212022202320242025
Revenue$8.4B$8.1B$8.8B$9.6B$10.3B
Operating Profit$450.0M$454.0M$963.0M$1.5B$2.2B
Net Profit$-948.0M$-225.0M$-592.0M$-46.0M$157.0M
EPS$-2.61$-0.62$-1.62$-0.13$0.43
Op Margin5.3%5.6%11.0%16.1%21.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$29.2B$25.7B$27.4B$26.5B$26.3B
Total Liabilities$29.2B$25.4B$27.4B$26.8B$25.9B
Cash$582.0M$564.0M$947.0M$1.2B$1.3B
Borrowings$22.7B$20.8B$22.4B$21.8B$21.2B

Latest News

Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026 PR Newswire · Jul 7, 2026 Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia CNW Group · Jul 6, 2026 Michael Goettler Resigns from Bausch Health's Board of Directors CNW Group · Jul 1, 2026 Health Care Roundup: Market Talk The Wall Street Journal · Jun 9, 2026 Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI® (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia CNW Group · Jun 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$1.4B$-728.0M$1.0B$1.6B$1.4B
Investing Cash Flow$126.0M$-571.0M$-2.4B$-791.0M$-992.0M
Financing Cash Flow$-173.0M$-139.0M$-106.0M$-69.0M$-94.0M
Net Cash Flow$303.0M$-1.5B$371.0M$239.0M$124.0M
Free Cash Flow$1.1B$-996.0M$760.0M$1.3B$1.0B

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA10.38
FCF Yield60.54%
Quick Ratio1.08
Interest Coverage1.72
Return 1Y-33.01%
Return 3Y-53.45%
Return 5Y-84.42%

Ownership

Insiders Held11.14%
Institutions Held65.07%
Institutions Float Held73.23%
Institutional HolderSharesReport Date
PAULSON & CO. INC.73,255,8692026-03-31
Goldentree Asset Management LP34,665,7312026-03-31
Royal Bank of Canada11,363,4982026-03-31
Nomura Holdings Inc.8,986,3722026-03-31
Healthcare of Ontario Pension Plan Trust Fund8,000,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALVOAlvotech $5.67 -3.08% -10.01 $1.92B 0.00%
ANIPANI Pharmaceuticals, Inc. $71.98 +0.07% 14.94 $1.64B 0.00%
BEAMBeam Therapeutics Inc. $24.60 -0.69% -29.88 $2.53B 0.00%
CONConcentra Group Holdings Parent, Inc. $36.61 +0.58% 23.00 $4.68B 0.70%
CPRX $31.49 +0.00% 18.00 $3.85B 0.00%

About Bausch Health Companies Inc.

Bausch Health Companies Inc. (BHC) stock trades at $6.04 with a market capitalization of $2.26B. The stock is valued at a price-to-earnings (P/E) ratio of -2.08, price-to-book of -1.30, price-to-sales of 0.21. Over the past 52 weeks the stock has ranged between $4.33 and $8.00, and currently trades 24.5% below its 52-week high.

On profitability, Bausch Health Companies Inc. generates a return on equity (ROE) of 88.77% — well above the market average, a sign of a high-quality business, return on capital employed of 13.63%, an operating margin of 21.28%, a net profit margin of -10.12%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides